(Q45259870)

11 December 2017

title

Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease (English)

1 reference

11 December 2017

1 reference

11

Morten Vatn

1 reference

11 December 2017

Reinhold W Stockbrugger

12

object named as

Reinhold W Stockbrügger

1 reference

11 December 2017

Erik J Schoon

1

1 reference

11 December 2017

Simona Bollani

2

1 reference

11 December 2017

Peter R Mills

3

1 reference

11 December 2017

Eran Israeli

4

1 reference

11 December 2017

Dieter Felsenberg

5

1 reference

11 December 2017

Sverker Ljunghall

6

1 reference

11 December 2017

Tore Persson

7

1 reference

11 December 2017

Louise Haptén-White

8

1 reference

11 December 2017

Hans Graffner

9

1 reference

11 December 2017

Gabriele Bianchi Porro

10

1 reference

11 December 2017

Matrix Study Group

13

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Clinical Gastroenterology and Hepatology

11 December 2017

published in

1 reference

11 December 2017

volume

3

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

113-121

1 reference

The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Reduced bone density in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Osteoporosis in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Low bone mineral density in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Increased bone resorption in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Osteoporosis and determinants of bone density in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

A controlled study of bone mineral density in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Bone disease in vitamin D-deficient patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Alterations in Bone Metabolism in Children with Inflammatory Bowel Disease: An In Vitro Study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Corticosteroids in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Corticosteroid-sparing treatments in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Treatment of inflammatory bowel disease in the elderly: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

A comparison of budesonide with prednisolone for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

A short questionnaire for the measurement of habitual physical activity in epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Interpretation of bone densitometry studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Bone mineral density in patients with recently diagnosed inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

Treatment of Crohn's disease with budesonide: this rose still has thorns!

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900662-7

7 January 2021

10.1016/S1542-3565(04)00662-7

Identifiers

DOI

1 reference

11 December 2017

1 reference